Clinical Trials Browser

Interventional × Melanoma × balstilimab × Clear all

NCT05561491 2023-06-22

A Study of ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients

Phase 2 Withdrawn

Melanoma, Neoplasm Metastasis